Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor suppression and...

Russia's mRNA cancer vaccine, launching in 2025, uses AI to personalise treatment, training the immune system to target cancer cells effectively.

Russia's mRNA cancer vaccine, launching in 2025, uses AI to personalise treatment, training the immune system to target cancer cells effectively.

Officials in Russia this week claimed to have developed a mRNA-based vaccine to treat cancer, which will be available for free to patients beginning...

The Russian Ministry of Health’s Radiology Medical Research Center has announced the development of a cancer vaccine, which will reportedly be...

Russia has announced the development of a pioneering mRNA vaccine against cancer, promising free access to patients by early 2025.

Russia has announced the development of a pioneering mRNA vaccine against cancer, promising free access to patients by early 2025.

Researchers from Qingdao University and the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences have...

The COVID-19 pandemic and recent Nobel Prize recognition have spotlighted mRNA therapies as a promising approach for diseases like cancer. Found in...

Scientists have developed CCI-38, a compound that targets YTHDF2 to improve CAR T cell therapy and overcome immune evasion in cancer.